Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Intellia Thera CS (NTLA)

Intellia Thera CS (NTLA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,572,037
  • Shares Outstanding, K 59,081
  • Annual Sales, $ 43,100 K
  • Annual Income, $ -99,530 K
  • 60-Month Beta 2.06
  • Price/Sales 58.55
  • Price/Cash Flow N/A
  • Price/Book 10.30
Trade NTLA with:

Options Overview

Details
  • Implied Volatility 112.37%
  • Historical Volatility 80.53%
  • IV Percentile 81%
  • IV Rank 42.10%
  • IV High 203.71% on 03/16/20
  • IV Low 45.95% on 08/25/20
  • Put/Call Vol Ratio 0.77
  • Today's Volume 496
  • Volume Avg (30-Day) 984
  • Put/Call OI Ratio 2.19
  • Today's Open Interest 14,613
  • Open Int (30-Day) 10,982

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.67
  • Number of Estimates 6
  • High Estimate -0.44
  • Low Estimate -0.81
  • Prior Year -0.63
  • Growth Rate Est. (year over year) -6.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.52 +6.98%
on 02/26/21
76.25 -20.71%
on 02/09/21
-3.79 (-5.90%)
since 01/26/21
3-Month
35.61 +69.78%
on 11/27/20
92.00 -34.28%
on 01/15/21
+24.60 (+68.60%)
since 11/25/20
52-Week
9.18 +558.61%
on 03/16/20
92.00 -34.28%
on 01/15/21
+48.16 (+391.54%)
since 02/26/20

Most Recent Stories

More News
Intellia (NTLA) Miss Earnings & Revenues Estimates in Q4

Intellia (NTLA) miss earnings and revenues estimates in the fourth quarter of 2020. Stock up.

NTLA : 60.46 (+5.20%)
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?

Style Box ETF report for FYC

FYC : 70.69 (+0.28%)
PLUG : 48.38 (+11.63%)
HOME : 25.19 (+6.42%)
IWO : 309.77 (+0.50%)
NTLA : 60.46 (+5.20%)
VBK : 281.66 (+0.47%)
Will Intellia Therapeutics, Inc. (NTLA) Report Negative Q4 Earnings? What You Should Know

Intellia Therapeutics, Inc. (NTLA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NTLA : 60.46 (+5.20%)
What's in the Cards for Intellia (NTLA) This Earnings Season?

Intellia Therapeutics (NTLA) is likely to discuss the progress of its pipeline candidate on its fourth-quarter earnings call.

REGN : 450.57 (-0.58%)
MRNA : 154.81 (+4.33%)
NVS : 85.91 (-0.92%)
NTLA : 60.46 (+5.20%)
Bear of the Day: CRISPR Therapeutics (CRSP)

Bear of the Day: CRISPR Therapeutics (CRSP)

NTLA : 60.46 (+5.20%)
EDIT : 43.86 (-2.01%)
CRSP : 125.69 (-1.25%)
ARKK : 130.36 (+0.66%)
ARKG : 93.51 (+0.41%)
Dow Alone in Record Territory

Dow Alone in Record Territory

PERI : 19.85 (+0.05%)
MXL : 39.77 (+1.66%)
SAH : 46.11 (+3.62%)
VSH : 23.87 (+1.06%)
AMZN : 3,092.93 (+1.17%)
VSAT : 51.14 (-2.44%)
NVTA : 40.13 (+0.83%)
NTLA : 60.46 (+5.20%)
ARTL : 1.8400 (-5.64%)
ACB : 10.52 (-2.77%)
CRON : 10.45 (-3.15%)
APHA : 17.84 (-2.09%)
CRTO : 34.39 (-3.02%)
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?

Style Box ETF report for FYC

FYC : 70.69 (+0.28%)
PLUG : 48.38 (+11.63%)
HOME : 25.19 (+6.42%)
IWO : 309.77 (+0.50%)
NTLA : 60.46 (+5.20%)
VBK : 281.66 (+0.47%)
The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics

The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics

VRTX : 212.55 (-0.20%)
NTLA : 60.46 (+5.20%)
CRSP : 125.69 (-1.25%)
CRISPR (CRSP) Up More Than 80% in Past 3 Months: Here's Why

CRISPR Therapeutics' (CRSP) lead gene-editing candidate CTX001, being developed for treating SCD and TDT, holds potential. It has a strong partner in Vertex.

VRTX : 212.55 (-0.20%)
EDIT : 43.86 (-2.01%)
NTLA : 60.46 (+5.20%)
CRSP : 125.69 (-1.25%)
Editas (EDIT) Up More Than 100% in Past 3 Months: Here's Why

Editas' (EDIT) lead candidate EDIT-101, that employs CRISPR gene editing to treat LCA10, holds potential. The company is also developing EDIT-301 for treating SCD.

ABBV : 107.74 (+0.38%)
EDIT : 43.86 (-2.01%)
NTLA : 60.46 (+5.20%)
CRSP : 125.69 (-1.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Intellia Therapeutics is a leading genome editing company, focused on developing therapeutics utilizing a biological tool known as CRISPR-Cas9 system. It believes the CRISPR-Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with...

See More

Key Turning Points

3rd Resistance Point 69.95
2nd Resistance Point 66.48
1st Resistance Point 63.47
Last Price 60.46
1st Support Level 56.98
2nd Support Level 53.51
3rd Support Level 50.50

See More

52-Week High 92.00
Last Price 60.46
Fibonacci 61.8% 60.36
Fibonacci 50% 50.59
Fibonacci 38.2% 40.82
52-Week Low 9.18

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar